Bide Pharmatech Co., Ltd.

¥66.93As of Sun 8 Nov 2026, 12:00 UTC
SSE:688073Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR 2.64%
Div yield 1.73%
ROE 9.42%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.58
PE TTM 29.67
TSR TTM (11.28%)
Mkt cap ¥5.766B
ROIC 17.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥66
(0.94%)
36.68%
Hold 0|4|5|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.03
1.07
1.19
1.14
11.50%
21.41%
21.64%
17.07%
Revenue¥M
615.6
607.9
605.6
620.0
4.10%
0.65%
0.40%
(0.70%)
Peers (US$864.4M)
Cap (US$)
PE
867.0M
41.80x
866.6M
46.93x
872.1M
978.4x
Capital
TTM
5Y
10Y
Leveragex
0.339
0.669
0.538
EBIT/Intx
1.322
0.420
0.497
Own earn%
(87.10)
(162.10)
(124.61)
Sh yield%
47.88
22.96
21.85
Owners
Insiders/Inst%
2.29
74.40
Short interest%
3.31
SBC / revenue%
3.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
16–27
$1 testx
—
Incr. ROIC%
6